UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 7, 2008
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
|
1-15525 |
|
36-4316614 |
|
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
|
|
|
|
|
|
|
One Edwards Way, Irvine, California |
|
92614 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
|
|
|
|
|
|
|
(949) 250-2500 |
||||
|
Registrant’s telephone number, including area code |
||||
|
|
|
|
|
|
|
N/A |
||||
|
(Former Name or Former Address, if Changed Since Last Report) |
||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On November 7, 2008, Edwards Lifesciences Corporation received notice from the New York Stock Exchange by certified mail that as a result of the death of Philip M. Neal, member of the Company’s Board of Directors and Audit and Public Policy Committee, the Company will be deemed non-compliant with NYSE Rule 303A.07(a), requiring that a listed company have three members on its audit committee, if a third member is not appointed to the Audit and Public Policy Committee by November 10, 2008. The Company plans to address this non-compliance at a meeting of its Board of Directors scheduled for November 13, 2008.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: November 10, 2008 |
|
|
|
|
|
|
|
|
EDWARDS LIFESCIENCES CORPORATION |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Denise E. Botticelli |
|
|
|
Denise E. Botticelli |
|
|
|
Vice President, Associate General Counsel |
|
|
|
and Secretary |
3